VISION NEWS SOURCE

X
X
X

Filters close
Newswise: Eye color genes are critical for retinal health
Released: 24-Mar-2023 3:40 PM EDT
Eye color genes are critical for retinal health
Max Planck Institute of Molecular Cell Biology and Genetics

Metabolic pathways consist of a series of biochemical reactions in cells that convert a starting component into other products. There is growing evidence that metabolic pathways coupled with external stress factors influence the health of cells and tissues.

Newswise: Tiny nanoparticle could have big impact on patients receiving corneal transplants
Released: 24-Mar-2023 3:25 PM EDT
Tiny nanoparticle could have big impact on patients receiving corneal transplants
Virginia Commonwealth University (VCU)

Corneal transplants can be the last step to returning clear vision to many patients suffering from eye disease. Each year, approximately 80,000 corneal transplantations take place in the U.S. Worldwide, more than 184,000 corneal transplantation surgeries are performed annually.

   
22-Mar-2023 9:00 AM EDT
Vision Research Funding Partnership Event Takes Place Today
Research to Prevent Blindness

Today, Research to Prevent Blindness (RPB) and more than 30 other organizations are convening in Washington DC for the Vision Research Funding Partnership event, which was organized around the theme of “The Research Pipeline – From Premise to Patient.”

Released: 22-Mar-2023 2:50 PM EDT
Cataract surgery reimbursements may not be enough for some patients
Michigan Medicine - University of Michigan

Research suggests that Medicare reimbursements for complex cataract surgery cover less than two minutes of operating time, and an increase to reimbursements for the procedure may be justified. Complex cataract surgery requires more time and resources than simple cataract surgery, and this study indicates that the incremental reimbursement for the complex surgery is not enough to offset the increased costs.

Released: 22-Mar-2023 12:10 PM EDT
UCLA Health Tip Sheet: Visual loss and mask-wearing practices; Influenza vaccination rates are low; Mixed ancestry study provides clues to genetic traits
University of California, Los Angeles (UCLA), Health Sciences

Below is a brief roundup of news and story ideas from the experts at UCLA Health. For more information on these stories or for help on other stories, please contact us at

Newswise: Effective treatment in rare but deadly form of cancer
Released: 21-Mar-2023 2:05 PM EDT
Effective treatment in rare but deadly form of cancer
University of Gothenburg

An advanced surgical therapy has proved considerably more efficacious than conventional treatments for patients with melanoma in the eye (uveal) that has spread to the liver, a University of Gothenburg study shows.

Newswise: Patients with family history of age-related macular degeneration should be screened by 55
Released: 21-Mar-2023 10:05 AM EDT
Patients with family history of age-related macular degeneration should be screened by 55
UT Southwestern Medical Center

Patients with a family history of age-related macular degeneration (AMD), the leading cause of permanent vision loss in those older than 60, should visit an ophthalmologist by age 55 to be screened for signs of the disease, advises an expert at UT Southwestern Medical Center.

access_time Embargo lifts in 2 days
Embargo will expire: 27-Mar-2023 6:15 PM EDT Released to reporters: 20-Mar-2023 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-Mar-2023 6:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-Mar-2023 9:00 AM EDT
Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel.
Newswise

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

     
Newswise: 新的基因编辑技术成功地逆转小鼠的视力损失
13-Mar-2023 9:55 AM EDT
新的基因编辑技术成功地逆转小鼠的视力损失
The Rockefeller University Press

视网膜色素变性症是人类失明的主要原因之一。中国的研究人员成功地恢复了患有视网膜色素变性症的小鼠的视力。该研究将于[三月十七日]发表在《实验医学杂志》上。该研究使用一种新型的、高度通用的CRISPR基因组编辑技术,有潜力纠正各种导致疾病的遗传突变。

Newswise: New gene-editing technique reverses vision loss in mice
13-Mar-2023 9:55 AM EDT
New gene-editing technique reverses vision loss in mice
The Rockefeller University Press

Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans. The study, to be published March 17 in the Journal of Experimental Medicine, uses a new, highly versatile form of CRISPR-based genome editing with the potential to correct a wide variety of disease-causing genetic mutations.

Newswise: Visually navigating on foot uses unique brain region
Released: 15-Mar-2023 8:45 AM EDT
Visually navigating on foot uses unique brain region
NIH, National Eye Institute (NEI)

Using vision to efficiently move through an area by foot uses a unique region of the brain’s cortex, according to a small study funded by the National Eye Institute (NEI).

Newswise: AI-based systems can help identify rapidly advancing age-related macular degeneration
Released: 14-Mar-2023 3:35 PM EDT
AI-based systems can help identify rapidly advancing age-related macular degeneration
NIH, National Eye Institute (NEI)

Researchers supported by the National Eye Institute are developing artificial intelligence/machine learning (AI/ML)-based systems that not only screen for AMD but also predict which patients will likely progress to late within two years. The systems also evaluate separately one’s risk for developing late wet (neovascular) AMD from one’s risk for late dry (geographic atrophy) AMD.

Newswise: The 2023 Shaffer Grants for Innovative Glaucoma Research
Released: 14-Mar-2023 1:30 PM EDT
The 2023 Shaffer Grants for Innovative Glaucoma Research
Glaucoma Research Foundation

Shaffer Grants provide seed funds to bold investigators whose creative projects explore promising leads and show strong potential for impact on glaucoma.

Released: 9-Mar-2023 11:55 AM EST
Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2023 Annual Meeting
Stuart Therapeutics

Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that it is sponsoring two research poster presentations by researchers at Vanderbilt University and the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which will take place from April 23-27, 2023, in New Orleans, Louisiana.

   
Newswise: New Insights: Eye Damage in Alzheimer’s Disease Patients
Released: 3-Mar-2023 10:05 AM EST
New Insights: Eye Damage in Alzheimer’s Disease Patients
Cedars-Sinai

Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond to brain and cognitive changes in Alzheimer’s disease patients.

Newswise: Smart contact lens with navigation function, made with 3D printer!
Released: 2-Mar-2023 7:30 PM EST
Smart contact lens with navigation function, made with 3D printer!
National Research Council of Science and Technology

Dr. Seol Seung-Kwon's team at the Korea Electrotechnology Research Institute published in international journals, implementing augmented reality by meniscus-guided printing.

Newswise: See clearly with these tips for safely using eye drops
Released: 2-Mar-2023 1:35 PM EST
See clearly with these tips for safely using eye drops
Michigan Medicine - University of Michigan

What should you consider when choosing the best kind of artificial tears for your eyes?

Newswise: Eye experts weigh in on artificial tears in midst of infectious outbreak
Released: 2-Mar-2023 1:15 PM EST
Eye experts weigh in on artificial tears in midst of infectious outbreak
NIH, National Eye Institute (NEI)

Questions remain about artificial tears linked to an outbreak of Pseudomonas aeruginosa infections involving 64 people in 13 states, including 8 cases of vision loss, as well as lung and urinary tract infections, and one death. Federal agencies warned people to stop using EzriCare and Delsam Pharma artificial tears after tests of opened bottles used by those affected found a rare, extensively drug-resistant strain of P. aeruginosa. The strain had never been reported in the United States.What is clear is that eye health experts have advice for people using artificial tears, which are sold over the counter and widely used for eye irritation associated with dry eye disease, contact lens use, and refractive surgery, as well among those using other eye drops regularly, such as for glaucoma.


Showing results

120 of 2064

close
0.44661